The NIH must reduce disparities in funding to maximize its return on investments from taxpayers.
Level V
Where this comes from
- Record sourced from PubMed, PMID 29570053.
- Also identified by DOI 10.7554/eLife.34965 and PMC identifier 5882298.
- Licence recorded as CC BY.
- The licence permits redistribution, so the abstract is shown in full and the full text is available from the publisher.
Abstract
New data from the NIH reveal that the scientific return on its sponsored research reaches a maximum at around $400,000 of annual support per principal investigator. We discuss the implications of this 'sweet spot' for funding policy, and propose that the NIH should limit both the minimum and maximum amount of funding per researcher.
Medical subject headings
- Biomedical Research
- Financing, Government
- Research Personnel
- Research Support as Topic